Share This Author
Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus.
Stress‐strain measurements of human and porcine corneas after riboflavin–ultraviolet‐A‐induced cross‐linking
Safety of UVA-Riboflavin Cross-Linking of the Cornea
Comparison of the currently used riboflavin/UVA approach with officially accepted guidelines regarding direct UV damage and the damage created by the induced free radicals shows that as long as the cornea treated has a minimum thickness of 400 μm, the corneal endothelium will not experience damage, nor will deeper structures such as lens and retina.
Complication and failure rates after corneal crosslinking
[Treatment of keratoconus by collagen cross linking].
The results show that collagen cross linking might be a useful conservative treatment modality to stop the progression of keratoconus and the need for keratoplasty might be significantly reduced.
Endothelial cell damage after riboflavin–ultraviolet‐A treatment in the rabbit
Increased resistance of crosslinked cornea against enzymatic digestion
The findings support the use of the new method in the treatment of corneal ulcers after a prolonged preservation especially of the anterior portion of the crosslinked corneas could be demonstrated.
Collagen crosslinking with ultraviolet‐A and hypoosmolar riboflavin solution in thin corneas
Ocular optical aberrations after photorefractive keratectomy for myopia and myopic astigmatism.
The increase in ocular aberrations was significantly related with the virtual pupil size, and Aberroscopy-guided photorefractive keratectomy may avoid such effects.
Collagen Fiber Diameter in the Rabbit Cornea After Collagen Crosslinking by Riboflavin/UVA
The crosslinking effect is strongest in the anterior half of the stroma because of the rapid decrease in UVA irradiance across the corneal stroma as a result of riboflavin-enhanced UVA absorption.